Osteoporosis caused by Glucocorticoid Treatment Not Yet Recruiting Phase 2 Trials for Alendronic acid (DB00630)

Also known as: Glucocorticoid Induced Osteoporosis / Steroid-induced osteoporosis / Osteoporosis, Steroid Induced / Osteoporosis caused by glucocorticoid / Osteoporosis caused by corticosteroid / Osteoporosis steroid-induced / Glucocorticoid-induced Osteoporosis / Osteoporosis caused by corticosteroid (disorder) / Osteoporosis due to corticosteroids (disorder) / Osteoporosis / Osteoporosis (disorder) / Osteoporosis NOS (disorder) / Involutional osteoporosis without current pathological fracture / Osteoporosis, unspecified / Osteoporosis NOS / Osteoporosis, unspecified (disorder)

DBCOND0129307 (Osteoporosis caused by Glucocorticoid Treatment)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05397938Efficacy and Safety of JMT103 in the Treatment of Glucocorticoid Induced OsteoporosisTreatment